FINDINGS OF SCIENTIFIC MISCONDUCT
RELEASE DATE: December 9, 2003
NOTICE: NOT-OD-04-014
Department of Health and Human Services (DHHS)
Notice is hereby given that the Office of Research Integrity (ORI) and the
Assistant Secretary for Health have taken final additional action in the
following case:
Kuei-Fu (Tom) Lin, D.V.M., Medical University of South Carolina (MUSC):
Based on the report of an investigation conducted by MUSC and additional
analysis conducted by ORI in its oversight review, the U.S. Public Health
Service (PHS) found on June 12, 2001, that Dr. Lin, a former graduate
student, Department of Biochemistry and Molecular Biology at MUSC, engaged in
scientific misconduct in research supported by the National Heart, Lung, and
Blood Institute (NHLBI), National Institutes of Health (NIH), grants R01
HL29397, Regulation and Function of Renal Kallikrein, and R01 HL56686,
Gene Therapy in Experimental Hypertension and Renal Diseases, by falsifying
data published in publications in Hypertension 26:847-853, 1995, Hypertension
Research 20:269-277, 1997, and Human Gene Therapy 9:1429-1438, 1998.
Subsequent to the execution of a three-year Voluntary Exclusion Agreement
(Agreement), Dr. Lin continued to receive PHS funds through April 30, 2003,
in material violation of the Agreement. Based on Dr. Lin’s aforementioned
violation, and in lieu of initiation of debarment proceedings authorized by
45 C.F.R. 76.305(c)(4) for Dr. Lin’s violation of a material provision of
the Agreement, the parties have agreed to extend the term of Dr. Lin’s
voluntary exclusion through April 29, 2007.
INQUIRIES
For further information contact:
Director
Division of Investigative Oversight
Office of Research Integrity
1101 Wootton Parkway, Suite 750
Rockville, MD 20852
Telephone: 301-443-5330
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|